Please login to the form below

Not currently logged in
Email:
Password:

Monsanto

This page shows the latest Monsanto news and features for those working in and with pharma, biotech and healthcare.

Bayer axes 1,250 pharma jobs, with R&D taking the brunt

Bayer axes 1,250 pharma jobs, with R&D taking the brunt

The shake-up – which follows its $66bn takeover of agricultural products company Monsanto – will also result in the sale of its animal health division to narrow its focus to pharma, consumer ... and agility.” He also insisted that the moves have

Latest news

More from news
Approximately 3 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Innovation in merger control and the impact on the pharmaceutical sector Innovation in merger control and the impact on the pharmaceutical sector

    This was its position in the recent Dow/ DuPont and Bayer/Monsanto mergers, where the Commission found that each transaction would have ‘significantly reduced competition in a number of markets’ and

  • Taking a lean and careful approach Taking a lean and careful approach

    He has also served as a group leader at Monsanto Co, a senior staff fellow at the National Institutes of Health and as an assistant professor at the University of Maryland.

  • Deal Watch May 2016 Deal Watch May 2016

    In the same vein, focusing its interests, Bayer put in a $62bn opening bid [$122 per share] to purchase Monsanto, which bid has been rejected as insufficient.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics